Journal article
Progress and Prospects: prospects of repeated pulmonary administration of viral vectors
Gene therapy, Vol.16(9), pp.1059-1065
2009
DOI: 10.1038/gt.2009.87
PMID: 19641533
Abstract
Pulmonary gene therapy may ultimately cure diseases such as cystic fibrosis, α1-antitrypsin deficiency, lung cancer and pulmonary hypertension. Efficient expression of delivered genes in target cell types is essential for the achievement of this goal. To this end, re-administration of viral vectors may be required (1) to increase the percentage of transduced airway epithelial cells, (2) to direct gene transfer to individual lobes during successive delivery sessions or (3) to boost attenuated expression over time. Immune responses to viral proteins or viral-encoded proteins are the greatest barrier to repeated vector administration.
Details
- Title: Subtitle
- Progress and Prospects: prospects of repeated pulmonary administration of viral vectors
- Creators
- P. L SINN - Program in Gene Therapy, Department of Pediatrics, Carver College of Medicine, The University of Iowa, Iowa City, IA, United StatesE. R BURNIGHT - Interdisciplinary Program in Genetics, Carver College of Medicine, The University of Iowa, Iowa City, IA, United StatesP. B MCCRAY - Program in Gene Therapy, Department of Pediatrics, Carver College of Medicine, The University of Iowa, Iowa City, IA, United States
- Resource Type
- Journal article
- Publication Details
- Gene therapy, Vol.16(9), pp.1059-1065
- DOI
- 10.1038/gt.2009.87
- PMID
- 19641533
- NLM abbreviation
- Gene Ther
- ISSN
- 0969-7128
- eISSN
- 1476-5462
- Publisher
- Nature Publishing Group
- Language
- English
- Date published
- 2009
- Academic Unit
- Microbiology and Immunology; Pulmonary Medicine; Stead Family Department of Pediatrics; Internal Medicine; Ophthalmology and Visual Sciences
- Record Identifier
- 9984093337002771
Metrics
29 Record Views